Long Chen is an experienced professional in the biotechnology field, currently serving as Associate Director of MSAT at Insmed Incorporated since August 2025. Long has had a diverse career, including roles as Senior Scientist and Senior Manager at Intellia Therapeutics, Inc., where significant contributions were made to in vivo gene therapy and AAV process development. Previous positions include Senior Scientist at Frontera Therapeutics, with expertise in Sf9 cell line development and AAV production, as well as a Scientist in process development at STC Biologics Inc., focusing on upstream and downstream processes. Long also completed a postdoctoral research fellowship at Northeastern University. Long holds a Bachelor's degree in Environmental Science from Wuhan University and a PhD in Chemical Engineering from the University of California, Riverside.
This person is not in the org chart
This person is not in any teams
This person is not in any offices